← Open Payments lookup

MARY CHELF: Open Payments

NPI 1821617077 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,644 in 141 payments from 20 companies in 2025. Trend: 2023 $1,293 · 2024 $2,605 · 2025 $2,644

Food & beverage: $2,644
CompanyPaymentsAmount
ABBVIE INC.47$695
Janssen Biotech, Inc.19$353
Takeda Pharmaceuticals U.S.A., Inc.13$294
Madrigal Pharmaceuticals7$181
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$173
Lilly USA, LLC6$148
Regeneron Healthcare Solutions, Inc.6$137
Biocon Biologics Inc5$98
Gilead Sciences, Inc.4$92
GENZYME CORPORATION4$78

Products named: RINVOQ, TREMFYA, ENTYVIO, DUPIXENT, REZDIFFRA, XIFAXAN, OMVOH, SKYRIZI.

Industry payments across OK — which companies pay providers there.